Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matyas

Showing results (1101-1110 of 1,118) with videos related to

Pageof 112
Sort By:
Vaccines|May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) ModelSara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Science (New York, N.Y.)|June 10, 2020
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern CaliforniaXianding Deng, Wei Gu, Scot Federman, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Circulation|June 18, 2013
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyStuart J Connolly, Lars Wallentin, Michael D Ezekowitz, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamstersKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
NPJ Vaccines|October 29, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challengeKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Pageof 112

Showing results (1101-1110 of 1,118) with videos related to

Sort By:
Pageof 112
Vaccines|May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) ModelSara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Science (New York, N.Y.)|June 10, 2020
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern CaliforniaXianding Deng, Wei Gu, Scot Federman, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Circulation|June 18, 2013
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyStuart J Connolly, Lars Wallentin, Michael D Ezekowitz, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamstersKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
NPJ Vaccines|October 29, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challengeKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Pageof 112